Compare ROIV & TSEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROIV | TSEM |
|---|---|---|
| Founded | 2014 | 1993 |
| Country | United Kingdom | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.2B | 25.7B |
| IPO Year | 2021 | 1996 |
| Metric | ROIV | TSEM |
|---|---|---|
| Price | $35.01 | $233.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 4 |
| Target Price | $28.94 | ★ $161.75 |
| AVG Volume (30 Days) | ★ 5.0M | 1.7M |
| Earning Date | 05-28-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,260,000.00 | N/A |
| Revenue This Year | N/A | $19.21 |
| Revenue Next Year | $744.61 | $26.62 |
| P/E Ratio | ★ N/A | $66.16 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.90 | $43.12 |
| 52 Week High | $37.00 | $319.94 |
| Indicator | ROIV | TSEM |
|---|---|---|
| Relative Strength Index (RSI) | 57.78 | 46.84 |
| Support Level | $33.56 | $201.54 |
| Resistance Level | $37.00 | $278.73 |
| Average True Range (ATR) | 1.11 | 17.81 |
| MACD | -0.24 | 1.68 |
| Stochastic Oscillator | 41.02 | 46.19 |
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Tower Semiconductor Ltd is a pure-play specialty foundry that manufactures semiconductors. As a pure-play foundry, it focuses on producing integrated circuits (ICs) based on the design specifications of customers. The company's line of integrated circuits is incorporated into markets, including consumer electronics, personal computers, communications, automotive, and industrial and medical device products. It produces ICs alongside wholly-owned subsidiaries through fabrication facilities located in Japan. The company has a geographical presence in the USA, Japan, Asia (other than Japan), and Europe.